Global Chronic Obstructive Pulmonary Disease Market Research Report 2024(Status and Outlook)

Global Chronic Obstructive Pulmonary Disease Market Research Report 2024(Status and Outlook)



Report Overview:

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.

The Global Chronic Obstructive Pulmonary Disease Market Size was estimated at USD 4113.67 million in 2023 and is projected to reach USD 4826.71 million by 2029, exhibiting a CAGR of 2.70% during the forecast period.

This report provides a deep insight into the global Chronic Obstructive Pulmonary Disease market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Chronic Obstructive Pulmonary Disease Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Chronic Obstructive Pulmonary Disease market in any manner.

Global Chronic Obstructive Pulmonary Disease Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AstraZeneca

GSK

MSD

Sunovion

Novartis

Roche Group

Pfizer

Jubilant Pharma Limited

Almirall

Horizon Pharma

Boehringer Ingelheim

Market Segmentation (by Type)

Bronchodilators

Glucocorticoids

Other

Market Segmentation (by Application)

Prevention

Diagnostic

Treatment

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Chronic Obstructive Pulmonary Disease Market

Overview of the regional outlook of the Chronic Obstructive Pulmonary Disease Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Chronic Obstructive Pulmonary Disease Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Chronic Obstructive Pulmonary Disease
1.2 Key Market Segments
1.2.1 Chronic Obstructive Pulmonary Disease Segment by Type
1.2.2 Chronic Obstructive Pulmonary Disease Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Chronic Obstructive Pulmonary Disease Market Overview
2.1 Global Market Overview
2.1.1 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Chronic Obstructive Pulmonary Disease Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Chronic Obstructive Pulmonary Disease Market Competitive Landscape
3.1 Global Chronic Obstructive Pulmonary Disease Sales by Manufacturers (2019-2024)
3.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Manufacturers (2019-2024)
3.3 Chronic Obstructive Pulmonary Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Chronic Obstructive Pulmonary Disease Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Chronic Obstructive Pulmonary Disease Sales Sites, Area Served, Product Type
3.6 Chronic Obstructive Pulmonary Disease Market Competitive Situation and Trends
3.6.1 Chronic Obstructive Pulmonary Disease Market Concentration Rate
3.6.2 Global 5 and 10 Largest Chronic Obstructive Pulmonary Disease Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Chronic Obstructive Pulmonary Disease Industry Chain Analysis
4.1 Chronic Obstructive Pulmonary Disease Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Chronic Obstructive Pulmonary Disease Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Chronic Obstructive Pulmonary Disease Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Chronic Obstructive Pulmonary Disease Sales Market Share by Type (2019-2024)
6.3 Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2019-2024)
6.4 Global Chronic Obstructive Pulmonary Disease Price by Type (2019-2024)
7 Chronic Obstructive Pulmonary Disease Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Chronic Obstructive Pulmonary Disease Market Sales by Application (2019-2024)
7.3 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) by Application (2019-2024)
7.4 Global Chronic Obstructive Pulmonary Disease Sales Growth Rate by Application (2019-2024)
8 Chronic Obstructive Pulmonary Disease Market Segmentation by Region
8.1 Global Chronic Obstructive Pulmonary Disease Sales by Region
8.1.1 Global Chronic Obstructive Pulmonary Disease Sales by Region
8.1.2 Global Chronic Obstructive Pulmonary Disease Sales Market Share by Region
8.2 North America
8.2.1 North America Chronic Obstructive Pulmonary Disease Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Chronic Obstructive Pulmonary Disease Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Chronic Obstructive Pulmonary Disease Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Chronic Obstructive Pulmonary Disease Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Chronic Obstructive Pulmonary Disease Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AstraZeneca
9.1.1 AstraZeneca Chronic Obstructive Pulmonary Disease Basic Information
9.1.2 AstraZeneca Chronic Obstructive Pulmonary Disease Product Overview
9.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease Product Market Performance
9.1.4 AstraZeneca Business Overview
9.1.5 AstraZeneca Chronic Obstructive Pulmonary Disease SWOT Analysis
9.1.6 AstraZeneca Recent Developments
9.2 GSK
9.2.1 GSK Chronic Obstructive Pulmonary Disease Basic Information
9.2.2 GSK Chronic Obstructive Pulmonary Disease Product Overview
9.2.3 GSK Chronic Obstructive Pulmonary Disease Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Chronic Obstructive Pulmonary Disease SWOT Analysis
9.2.6 GSK Recent Developments
9.3 MSD
9.3.1 MSD Chronic Obstructive Pulmonary Disease Basic Information
9.3.2 MSD Chronic Obstructive Pulmonary Disease Product Overview
9.3.3 MSD Chronic Obstructive Pulmonary Disease Product Market Performance
9.3.4 MSD Chronic Obstructive Pulmonary Disease SWOT Analysis
9.3.5 MSD Business Overview
9.3.6 MSD Recent Developments
9.4 Sunovion
9.4.1 Sunovion Chronic Obstructive Pulmonary Disease Basic Information
9.4.2 Sunovion Chronic Obstructive Pulmonary Disease Product Overview
9.4.3 Sunovion Chronic Obstructive Pulmonary Disease Product Market Performance
9.4.4 Sunovion Business Overview
9.4.5 Sunovion Recent Developments
9.5 Novartis
9.5.1 Novartis Chronic Obstructive Pulmonary Disease Basic Information
9.5.2 Novartis Chronic Obstructive Pulmonary Disease Product Overview
9.5.3 Novartis Chronic Obstructive Pulmonary Disease Product Market Performance
9.5.4 Novartis Business Overview
9.5.5 Novartis Recent Developments
9.6 Roche Group
9.6.1 Roche Group Chronic Obstructive Pulmonary Disease Basic Information
9.6.2 Roche Group Chronic Obstructive Pulmonary Disease Product Overview
9.6.3 Roche Group Chronic Obstructive Pulmonary Disease Product Market Performance
9.6.4 Roche Group Business Overview
9.6.5 Roche Group Recent Developments
9.7 Pfizer
9.7.1 Pfizer Chronic Obstructive Pulmonary Disease Basic Information
9.7.2 Pfizer Chronic Obstructive Pulmonary Disease Product Overview
9.7.3 Pfizer Chronic Obstructive Pulmonary Disease Product Market Performance
9.7.4 Pfizer Business Overview
9.7.5 Pfizer Recent Developments
9.8 Jubilant Pharma Limited
9.8.1 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Basic Information
9.8.2 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Overview
9.8.3 Jubilant Pharma Limited Chronic Obstructive Pulmonary Disease Product Market Performance
9.8.4 Jubilant Pharma Limited Business Overview
9.8.5 Jubilant Pharma Limited Recent Developments
9.9 Almirall
9.9.1 Almirall Chronic Obstructive Pulmonary Disease Basic Information
9.9.2 Almirall Chronic Obstructive Pulmonary Disease Product Overview
9.9.3 Almirall Chronic Obstructive Pulmonary Disease Product Market Performance
9.9.4 Almirall Business Overview
9.9.5 Almirall Recent Developments
9.10 Horizon Pharma
9.10.1 Horizon Pharma Chronic Obstructive Pulmonary Disease Basic Information
9.10.2 Horizon Pharma Chronic Obstructive Pulmonary Disease Product Overview
9.10.3 Horizon Pharma Chronic Obstructive Pulmonary Disease Product Market Performance
9.10.4 Horizon Pharma Business Overview
9.10.5 Horizon Pharma Recent Developments
9.11 Boehringer Ingelheim
9.11.1 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Basic Information
9.11.2 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Overview
9.11.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease Product Market Performance
9.11.4 Boehringer Ingelheim Business Overview
9.11.5 Boehringer Ingelheim Recent Developments
10 Chronic Obstructive Pulmonary Disease Market Forecast by Region
10.1 Global Chronic Obstructive Pulmonary Disease Market Size Forecast
10.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Chronic Obstructive Pulmonary Disease Market Size Forecast by Country
10.2.3 Asia Pacific Chronic Obstructive Pulmonary Disease Market Size Forecast by Region
10.2.4 South America Chronic Obstructive Pulmonary Disease Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Chronic Obstructive Pulmonary Disease by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Chronic Obstructive Pulmonary Disease Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Chronic Obstructive Pulmonary Disease by Type (2025-2030)
11.1.2 Global Chronic Obstructive Pulmonary Disease Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Chronic Obstructive Pulmonary Disease by Type (2025-2030)
11.2 Global Chronic Obstructive Pulmonary Disease Market Forecast by Application (2025-2030)
11.2.1 Global Chronic Obstructive Pulmonary Disease Sales (K Units) Forecast by Application
11.2.2 Global Chronic Obstructive Pulmonary Disease Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings